Galectin‐3 Is Elevated and Associated With Adverse Outcomes in Patients With Single‐Ventricle Fontan Circulation

Journal of the American Heart Association

  ^{1    2    3    3    4    4    4    4    4    5    6} 

[1] Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA;Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, MA;Cincinnati Children's Hospital Heart Institute, Cincinnati, OH;Department of Cardiology, Boston Children's Hospital, Boston, MA;Department of Medicine, Brigham and Women's Hospital, Boston, MA;Department of Cardiology, Boston Children's Hospital, Boston, MA;Department of Medicine, Brigham and Women's Hospital, Boston, MA;Framingham Heart Study, Framingham, MA;División de Enfermedades Cardiovasculares, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile;

关键词: adult congenital heart disease;    biomarker;    congenital heart disease;    Fontan procedure;    galectin‐3;   

DOI  :  10.1161/JAHA.115.002706

来源: publisher

【 授权许可】

Unknown